MedTrace Logo

Effects of Incentive Spirometry With and Without Aerobic Exercises in Interstitial Lung Disease

NCT06133998 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2023-11-18

No results posted yet for this study

Summary

Effects of Incentive spirometry with and without Aerobic exercises on dyspnea, exercise capacity and quality of life in interstitial lung disease

Conditions

Interventions

DEVICE

incentive spirometer with aerobic exercises

Group A: Aerobic exercise (running, jugging, cycling, walking) will be given to the group A for the checking the effect of incentive spirometer * In sitting position, for the relaxation of body, patient will take a deep breath. * In sitting position, patient will sit on the chair, placed both feet on the floor while bending knee at 90 degree and use the incentive spirometer for the deep breath and check the volume of lung. This schedule will be following supervised exercise training for a minimum 60 minutes 3 days a week in moderate patient,75 minutes in moderate to vigorous patients and 150 minutes in healthy patients * We will check the dyspnea of the patient by the borage scale * We will check the exercise capacity by the endurance training of respiratory muscles and use the 6 mint walk test * We will check the quality of life by the questionnaire.

DEVICE

incentive spirometry without aerobic exercises

Group B: In group B we will check the effects of incentive spirometer without the aerobic exercise. * In aerobic exercise following treatment protocol will be involve * In sitting position, for the relaxation of body, patient will take a deep breath. * In sitting position, patient will sit on the chair, placed both feet on the floor while bending knee at 90 degree and use the incentive spirometer for the deep breath and check the volume of lung. * We will check the dyspnea of the patient by the borage scale * We will check the exercise capacity by the endurance training of respiratory muscles and use the 6 mint walk test * We will check the quality of life by the questionnaire. * We will check the chest expansion by measuring tap.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • sumera abdul hameed, Ms · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-20
Primary Completion
2023-12-01
Completion
2023-12-10

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06133998 on ClinicalTrials.gov